Child and Adolescent Psychopharmacology

 

According to the National Institute of Mental Health, children and adolescents handle medications differently than adults. The brains of children and adolescents are still growing and developing in complexity, and the younger the child, the more development still has to take place. It is important to note that most medications were originally developed to treat mental health disorders in adults. Children’s livers, kidneys, and gastrointestinal tracts, which are involved in metabolizing medications, may also be at different levels of development and functioning in comparison to adults. Pharmaceutical companies have not done the studies necessary to obtain FDA approval for many, if not most, of the medications that are used to treat mental health problems in children. In 1997, the U.S. congress passed laws offering incentives for drug manufacturers to test medications in children and adolescents, but due to ethical concerns over testing the medications in children, most psychiatric medications have not undergone the rigorous testing necessary to gain FDA approval. Children are considered more vulnerable than adults are, and require parental or guardian consent to receive prescriptions as well as to enroll in clinical pharmaceutical research. Therefore, it tends to be more difficult and costly for drug companies to obtain approval for specific medications to treat the various mental health disorders and symptoms. Despite the relatively few medications with FDA approval, many medications are used to treat children and adolescent mental health disorders. Providers can do this legally, and when medications are prescribed for specific indications for which they have not received FDA approval, this is called “off-label prescribing.” Most of the medications used to treat child and adolescent mental health conditions are probably prescribed off label. Through research, scientists continue to learn the specific needs and precautions to take when treating children and adolescents. Some younger individuals may be more comfortable speaking with a mental health professional about their medications and any side effects, rather than the person who prescribed their medication. Hence, as a mental health professional, it is important for you to be familiar with child and adolescent psychopharmacology. By having some familiarity of the medications that are used in youth and their potential side effects, you will be able to help clients and their guardians understand when to approach the provider with concerns and how to discuss those concerns. The course covers a variety of medications, including antipsychotics, stimulants, mood stabilizers, and others. You will learn about the unique issues surrounding psychopharmacology for pediatric populations, including common uses, side effects, and timelines for medication response. Through interactive games, quizzes, and vignettes, this course will help you to take the learning back to your real-world work environment. This course is appropriate for non-MD mental health professionals, including marriage/family therapists, and licensed clinical social workers. DSM™ and DSM-5™ are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this course. This module is text-based.

Child and Adolescent Psychopharmacology is rated 5.0 out of 5 by 1.
  • y_2017, m_12, d_12, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.3
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_c371466, prod, sort_[SortEntry(order=RELEVANCE, direction=DESCENDING)]
  • clientName_relias
  • bvseo_sdk, java_sdk, bvseo-3.1.1
  • CLOUD, getAggregateRating, 0ms
  • REVIEWS, PRODUCT

$19.95

Hours: 1.50 - 1.75
REL-HHS-0-CAP-V2

Certificates

Certificates provided by accrediting body (31 Match)

American Psychological Association

1.75 HOURS


Relias Learning, LLC is approved by the American Psychological Association to sponsor continuing education for psychologists. Relias Learning maintains responsibility for this program and its content. This activity is approved for 1.75 contact hours.

California Board of Registered Nursing

1.75 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 1.75 contact hours for participating in this course.

District of Columbia Board of Nursing

1.7 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 1.70 contact hours for participating in this course.

Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling

1.75 HOURS


Provider #50-290 This activity is approved for 1.75 contact hours.

Illinois Professional Counselor/Clinical Counselor

1.75 HOURS


This activity is approved for 1.75 contact hours.

National Board for Certified Counselors

1.5 HOURS







Relias Learning, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No.6110. Programs that do not qualify for NBCC credit are clearly identified. Relias Learning, LLC is solely responsible for all aspects of the programs. This activity is approved for 1.50 contact hours

Ohio Marriage and Family Therapist Board

1.75 HOURS


Provider # RTX050401
This activity is approved for 1.75 contact hours.

Ohio Professional Counselor Board

1.75 HOURS


Provider # RCX100502
This activity is approved for 1.75 contact hours.

Texas State Board of Professional Counselors

1.75 HOURS


This activity is approved for 1.75 contact hours.

Florida Board of Nursing CE

1.5 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 1.50 contact hours for participating in this course.

Texas State Board of Examiners of Marriage and Family Therapists

1.75 HOURS


This activity is approved for 1.75 contact hours.

American Nurses Credentialing Center

1.75 HOURS


Relias Learning, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 1.75 contact hours for participating in this course.

Association of Social Work Boards (RL)

1.75 HOURS


Relias Learning, LLC, #1273, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. Relias Learning, LLC maintains responsibility for the program. ASWB Approval Period: 2/10/2015-2/10/2018. Social workers should contact their regulatory board to determine course approval for continuing education credits.

Course Delivery Format: Asynchronous Distance Learning-interaction includes quizzes with questions and answers, posttests. This module is Text-based.

Social workers participating in this course will receive 1.75 Clinical continuing education clock hours. This activity is approved for 1.75 contact hours.

New York State Education Department, Office of the Professions, Division of Professional Licensing Services, Social Work Unit

1.75 HOURS


Relias Learning, LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0009.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.

As a provider of online, asynchronous education, some courses offered by Relias Learning are considered “self-study” under section 74.10(c)(2)(ii)(b)(4) of the Commissioner’s Regulations. The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.

Social workers will receive 1.75 continuing education hours for participating in this course. This activity is approved for 1.75 contact hours.

Florida Board of Psychology

1.7 HOURS


Georgia Board of Nursing

1.75 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 1.75 contact hours for participating in this course.

State Of Illinois, Department of Financial and Professional Regulation, Marriage and Family Therapist Continuing Education Sponsor

1.75 HOURS


This activity is approved for 1.75 contact hours.

Oklahoma- Northamerican Association of Masters in Psychology

1.75 HOURS


Oklahoma- Northamerican Association of Masters in Psychology


This activity is approved for 1.75 contact hours.

Accreditation Council for Continuing Medical Education

1.75 HOURS


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Relias Learning. Relias Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Relias Learning designates this enduring material activity for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Florida Board of Medicine

1.75 HOURS


Florida Board of Medicine CE Provider #: 50-290

Connecticut Certification Board

1.75 HOURS


This activity is approved for 1.75 contact hours.

Florida Physician Assistants

1.75 HOURS


Ohio Chemical Dependency Professionals Board

1.75 HOURS


This activity is approved for 1.75 contact hours. Content Area: C6, R1

The Breining Institute for Registered Addiction Specialists

1.75 HOURS


This activity is approved for 1.75 contact hours.

Michigan Certification Board for Addiction Professionals

1.75 HOURS


Education hours MCBAP-S
This activity is approved for 1.75 contact hours.

Missouri Credentialing Board

1.75 HOURS


This activity is approved for 1.75 contact hours.

California Consortium of Addiction Programs and Professionals

1.75 HOURS


Provider approved by CCAPP, Provider number 1S-06-729-0218 for 1.75 CEH's

California Association of Alcohol and Drug Educators

1.75 HOURS


Relias Learning is an approved provider of Continuing Education. Provider number: CP40 910 H 0318 for 1.75 CEHs.

Louisiana Addictive Disorder Regulatory Authority

1.75 HOURS


This activity is approved for 1.75 contact hours.

NAADAC, The Association for Addiction Professionals

1.75 HOURS


This course has been approved by Relias Learning, as a NAADAC Approved Education Provider, for 1.75 CE. NAADAC Provider #86124, Relias Learning is responsible for all
aspects of their programming.

Association of Social Work Boards - New Jersey

1.75 HOURS


This course is approved by the Association of Social Work Boards - ASWB NJ CE Course Approval Program Provider #37 Course #1399 from 8.24.2017 to 8.24.2019. Social workers will receive the following type and number of credit(s): Clinical Social Work Practice 1.75.

New Jersey social workers not pleased with a grievance resolution provided by Relias Learning, LLC may appeal to the approving entity or their jurisdictional board.

Course Delivery Method and Format: Asynchronous Distance Learning Text-based

Course Details

Course Code: REL-HHS-0-CAP-V2
Hours: 1.75
Type: Online Course
Content Expiration Date: 7/31/2019
Learning Objectives:
Describe the different classes of psychotropic medications used to treat childhood and adolescent psychiatric disorders.
Discuss the uses and side effects of psychotropic medications commonly prescribed for psychiatric disorders in children and adolescents.
Explain the unique childhood and adolescent presentations of common psychiatric illnesses.

Outline:
Section 1: Introduction
A. About This Course
B. Learning Objectives

Section 2: Antidepressants
A. Meet Jenny
B. Overview of Antidepressants
C. Overview of the SSRIs
D. Adverse Effects of the SSRIs
E. Adverse Effects of the SSRIs
F. Additional Adverse Effects of the SSRIs
G. FDA Black Box Warning
H. Tricyclic Antidepressants
I. Monoamine Oxidase Inhibitors
J. Other Antidepressants
K. Diagnosing Depression/Anxiety in Children and Adolescents
L. Let’s Review
M. Meet Michelle
N. Summary

Section 3: ADHD Medications
A. Overview
B. Specific Information about Stimulants
C. Adverse Effects
D. Stimulants and Tic Disorders
E. Risk for Cardiac Problems
F. ADHD, Stimulants, Bipolar Disorder, and Psychosis
G. Stimulants and Addiction
H. Other Medications for ADHD
I. Intuniv® and Kapvay®
J. Meet Matthew
K. Summary

Section 4: Antipsychotics and Mood Stabilizers
A. Overview of Antipsychotics
B. Adverse Effects
C. Specific Information about Each Antipsychotic
D. Recent Atypical Antipsychotic Medications
E. Diagnosing Bipolar Disorder in Children and Adolescents
F. Disruptive Mood Dysregulation Disorder
G. Overview of Mood Stabilizers
H. Specific Information about Each Mood Stabilizer
I. Meet Robert
J. Summary

Section 5: Other Medications
A. Benadryl®/Vistaril®
B. Trazodone®
C. Buspar®
D. Benzodiazepines
E. Medications for Tics
F. Sleep Difficulties
G. Enuresis
H. Let's Review
I. Summary

Section 6: Conclusion
A. Summary
B. Congratulations!
C. Course Contributor
D. References

Staff Writer: Steve Jenkins, Ph.D.
Dr. Jenkins is a Counseling Psychologist, and a professor of psychology at Wagner College in New York. He teaches a variety of courses, including Health Psychology, Psychological Testing, Psychopathology, Sleep and Dreams, Principles of Counseling Psychology, and Positive Psychology. He also has extensive clinical experience, and has worked in prisons, hospitals, outpatient clinics, and college counseling centers providing individual and group psychotherapy, as well as psychoeducational workshops. He is an associate fellow of the Albert Ellis Institute for Rational Emotive Behavioral Therapy and completed a year-long post-doctoral training at the institute. Dr. Jenkins scholarly works have been published in top psychological journals and edited books, and presented at national conferences. Disclosure: Steve Jenkins, Ph.D. has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Expert Reviewer: David Patzer, MD
David Patzer, M.D. has been practicing child, adolescent, and adult psychiatry for nearly 20 years. His education includes an undergraduate degree from Illinois Wesleyan University and his medical degree from Northwestern Medical School in Chicago, Illinois. He completed residency training in General Adult Psychiatry at Yale University and Child and Adolescent Psychiatry Fellowship training at the Yale University Child Study Center. Dr. Patzer served as Assistant Professor at Yale and subsequently at the University of Arizona in Tucson teaching child psychiatry. He also attended the Addiction Psychiatry Fellowship at Vanderbilt University. Dr. Patzer is board certified in general psychiatry, child and adolescent psychiatry, and addiction medicine, as well as licensed for practice in both Tennessee and Arizona. He has served in numerous director-level positions for child and adolescent psychiatry. He has also published numerous articles on developmental disorders and substance use disorders. Dr. Patzer currently serves as the Adult and Child and Adolescent Psychiatrist and Clinical Supervisor for Mental Health Cooperative in Nashville, Tennessee. He is also the Medical Director for the Middle Tennessee Bradford Health Services (Addiction Treatment) in Nashville, Franklin, and Clarksville, Tennessee. Disclosure: David Patzer, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry level Psychologists; intermediate and advanced level Nurses; intermediate and advanced level Social Workers; intermediate level Professional Counselors; in the following settings: Health and Human Services; and the following practice categories: General Nursing.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.
Accommodations
If you require special accommodations to complete this module, please contact Relias Learning Customer Support by calling (800) 381-2321 or emailing support@reliaslearning.com